Table 8.
Classification results from repeated 10-fold cross-validation and repeated double cross-validation on urine samples from patients with bladder cancer and patients with haematuria and or prostatic symptoms. LDA = linear discriminant analysis; and SVM-P = support vector machine; and CI = confidence interval of mean values.
Repeated 10-Fold cross-validation | |||||||||
---|---|---|---|---|---|---|---|---|---|
Accuracy | Sensitivity | Specificity | |||||||
Classifier | Mean | Median | CI | Mean | Median | CI | Mean | Median | CI |
LDA | 96.4 | 100.0 | [94.2-98.3] | 92.1 | 100.0 | [90.4-93.6] | 97.8 | 100.0 | [95.5-99.5] |
SVM-P | 97.1 | 100.0 | [95.5-98.8] | 88.6 | 100.0 | [82.0-94.7] | 100.0 | 100.0 | [99.4-100.0] |
Repeated double cross-validation | |||||||||
Accuracy | Sensitivity | Specificity | |||||||
Classifier | Mean | Median | CI | Mean | Median | CI | Mean | Median | CI |
LDA | 93.6 | 93.8 | [92.1-95.1] | 87.4 | 87.5 | [84.0-90.5] | 95.7 | 95.8 | [94.1-97.1] |
SVM-P | 96.2 | 96.9 | [95.3-97.2] | 87.2 | 87.5 | [83.5-91.0] | 99.2 | 100.0 | [98.5-99.8] |